World Bank Approves Health Resilience Project to Protect Lives and Strengthen Emergency Response in Mozambique
The World Bank has approved the Mozambique Health Emergency Preparedness, Response and Resilience Project, an initiative to strengthen the health system's ability to deliver essential services consistently and equitably. The project targets underserved and climate-vulnerable areas by investing in human resources, infrastructure, and systems that ensure continuity of care during emergencies. This project is part of a regional p rogram to strengthen health security across Eastern and Southern Africa.
Mozambique faces frequent floods, cyclones, disease outbreaks, and other emergencies that disrupt health services and put lives at risk. Many communities lack sufficient and trained health workers, access to essential medicines, and the tools to detect and respond quickly to crises. The project seeks to address these gaps by:
Strengthening the health workforce capacity, particularly in high-risk areas, by improving recruitment, training, and retention systems;
Improving pharmaceutical supply chains by supporting the regulatory agency in bringing more transparency and speed to procurement processes, lowering and standardizing prices of health commodities to ensure access to medicines, particularly during crises; and
Enhancing disease surveillance and laboratory capacity to improve early warning and response systems to quickly detect and respond to health emergencies like cholera outbreaks or heatwaves.
The project also supports the development of climate-adaptive infrastructure and emergency preparedness plans, recognizing the growing health risks posed by climate change.
' Mozambique is already experiencing the health impacts of shocks and emergencies,' noted Luc Lecuit, World Bank Acting Division Director in Mozambique. 'The program supports the government's efforts to strengthen core health service delivery by investing in preparedness and resilience, ensuring services remain operational during floods, storms, and epidemics.'
Financed through a $201 million grant from the International Development Association (IDA)*, the initiative will be implemented over five years, concluding in September 2030.
'By prioritizing practical investments in the foundational pillars of the health sector, the Government of Mozambique is driving greater efficiency across the system and strengthening its emergency response capacity to protect lives,' said João Pires, World Bank Senior Health Specialist and Task Team Leader. 'These efforts are paving the way for bold reforms to ensure the health system remains resilient and responsive, even under pressure.'
In parallel, the World Bank, together with other development partners, is increasing its support to the Mozambique health sector through a $63.7 million top-up to the ongoing District and Community Health Services Revitalization Project. This additional financing—comprising $8.7 million from IDA, $5 million from the Global Financing Facility, and $50 million from a multi-donor trust fund supported by Canada, the United Kingdom, and Ireland—will expand the project's impact across the most vulnerable 63 districts of Mozambique. The operation focuses on improving access to quality primary health care, particularly for women, children, and adolescents, and strengthening service delivery at the district and community levels.
Both projects align with the forthcoming Mozambique's Health Sector Strategic Plan (PESS, 2025-2034) (PESS 2020–2024) and the National Adaptation Plan (2023), and complement regional efforts to strengthen health security across Eastern and Southern Africa.
Distributed by APO Group on behalf of The World Bank Group.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
5 hours ago
- Zawya
South Africa's Biovac to make, distribute pneumonia vaccine across Africa
Cape Town-based biopharmaceutical company Biovac has signed a transfer agreement with Biological E in India to manufacture and distribute a pneumonia vaccine across Africa. Biological E's PCV14 – a 14-valent pneumococcal conjugate vaccine, having broad serotype coverage – was found to be non-inferior to Prevenar 13 for all shared serotypes in the pivotal phase-three randomised, active control trial. Biological E's PCV14 vaccine is already licensed in India and is currently undergoing World Health Organisation (WHO) prequalification with the aim being to make the vaccine available to Unicef and Gavi markets soon thereafter. In parallel, a technology transfer is being initiated with Biovac that is anticipated to take three years including regulatory approval. Pneumococcal infection, which the vaccine protects against, is a cause of significant disease, being a leading cause of pneumonia, bacterial meningitis, and sepsis. WHO estimated that in 2005, pneumococcal infections were responsible for the death of 1.6 million children worldwide and while this has reduced significantly over time, newer and better vaccines are still needed. Dr Morena Makhoana, Biovac CEO, states: 'Biovac is on a steady journey of ensuring that it expands its footprint beyond South Africa. We do so by carefully selecting our partners and the type of products that meet our customers' needs.

Zawya
5 hours ago
- Zawya
Stronger Health Through Smarter Taxes in Mauritius
WHO has joined forces with VISA NGO and the University of Cape Town to assess the impact of increasing health taxes in Mauritius. Using a simulation tool, the study examined how tax hikes affect tobacco use, government revenues, and premature deaths. A 15% annual cigarette tax increase could: Boost excise revenue by 55% Reduce smoking prevalence from 18.1% to 17.4% Prevent 11,600 premature deaths by 2029 Even more ambitious action—a 25% annual increase—could: Double excise revenues Lower smoking prevalence to 16.3% Save 19,300 lives by 2029 On 20 June 2025, WHO convened high-level officials from the Ministries of Health and Finance to discuss the findings, presented by the University of Cape Town's Research Unit on the Economics of Excisable Products and a WHO taxation expert. WHO and VISA echoed the study's call for regular, significant tax increases—one of the most effective ways to curb noncommunicable diseases (NCDs) Earlier, on 26 May, VISA and WHO presented the findings to key stakeholders including the Mauritius Revenue Authority, Ministries of Education and Youth, the University of Mauritius, NGOs, and consumer groups. WHO also applauded the Government's recent decision to raise taxes by 10% on tobacco and alcohol, and 100% on sugary drinks, extending it to products like chocolate and ice cream. 'This is a gift to public health,' said Dr. Anne Ancia, WHO Representative. 'Higher prices on unhealthy products help reduce consumption—especially in a country where obesity, diabetes and cardio-vascular diseases are leading causes of death and disability.' Dr. Ancia also stressed the urgent need to enforce the Tobacco Law 2022, particularly the ban on single-stick sales, which undermines progress in reducing tobacco use through higher prices. Distributed by APO Group on behalf of World Health Organization (WHO) - Mauritius.


Zawya
7 hours ago
- Zawya
Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions. Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region. Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects. 'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the region.' Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships. 'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care. On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks. In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs. 'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said. She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.' As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical. Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population. With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (